Welcome to our dedicated page for Cohen & Steers SEC filings (Ticker: CNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating AUM shifts, fee margin details and REIT exposure inside Cohen & Steers’ 300-page disclosures can feel like searching for a needle in a footnote. If you have ever asked, “How do I read the Cohen & Steers annual report 10-K simplified?” or “Where are the Cohen & Steers insider trading Form 4 transactions listed in real time?”, you already know how complex an asset-manager filing can be.
Stock Titan solves that problem. Our AI instantly turns every new Cohen & Steers quarterly earnings report 10-Q filing, 8-K event notice or Cohen & Steers proxy statement executive compensation into plain-English insights. Need to monitor Cohen & Steers Form 4 insider transactions real-time? Want a concise Cohen & Steers earnings report filing analysis that flags AUM growth, fee rate changes and segment performance across liquid real assets? Our platform answers those questions while the document is still hitting EDGAR.
Here is what you can expect the moment CNS files:
- AI-powered summaries that explain complex sections—perfect for understanding Cohen & Steers SEC documents with AI.
- Real-time alerts on executive stock transactions, so you never miss Cohen & Steers executive stock transactions Form 4.
- Line-by-line highlights of 10-K risk factors tied to property cycles, infrastructure regulation and preferred-security credit risk.
- Easy navigation to 8-K items—material fund launches or AUM updates—so Cohen & Steers 8-K material events explained becomes a single click.
Whether you track insider sentiment before allocating capital, compare quarter-over-quarter AUM growth, or dissect fee income trends, our AI lets you move from data to decision faster. Make informed portfolio calls without sifting through hundreds of pages—everything you need from Cohen & Steers SEC filings explained simply is right here.
Cohen & Steers, Inc. (CNS)11/20/2025, the reporting person acquired 1,401 shares of common stock at a price of $0, reported as an acquisition of dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend and accruing on previously granted unvested restricted stock units from January 2022, 2023, 2024 and 2025.
Following this transaction, the reporting person directly beneficially owns 1,288,432 shares of common stock. In addition, 305,000 shares are held indirectly through a limited liability company owned by a family trust, for which the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.
Cohen & Steers, Inc. (CNS) executive vice president reported an automatic share-based accrual tied to company dividends. On 11/20/2025, the officer acquired 220 shares of common stock at a price of $0, reflecting dividend equivalent restricted stock units credited in connection with the issuer's fourth quarter 2025 dividend. These units accrued on unvested restricted stock units previously granted in June 2024 and January 2025. Following this transaction, the officer beneficially owned 23,123 shares of Cohen & Steers common stock, held directly.
Cohen & Steers, Inc. (CNS)11/20/2025, the officer acquired 227 shares of common stock at a price of $0. These shares are described as dividend equivalent restricted stock units that accrued on earlier unvested restricted stock unit grants from January 2022, January 2023, January 2024 and January 2025 in connection with the company’s fourth quarter 2025 dividend. After this transaction, the officer beneficially owns 528,903 shares of Cohen & Steers common stock, held directly. This filing reflects compensation-related accruals rather than an open-market purchase or sale.
Cohen & Steers, Inc. (CNS)
Following this transaction, the executive directly beneficially owns 10,314 CNS shares. No derivative securities transactions were reported.
Cohen & Steers, Inc. (CNS)11/20/2025, the officer acquired 187 shares of common stock at a price of $0. These shares represent dividend equivalent restricted stock units credited in connection with the company’s fourth quarter 2025 dividend on previously granted unvested restricted stock units from May 2023, January 2024, January 2025 and October 2025. After this transaction, the officer beneficially owns 26,205 shares of Cohen & Steers common stock directly.
Cohen & Steers, Inc. (CNS)11/19/2025, trusts associated with him bought additional CNS common stock in open-market purchases.
The Robert H. Steers 2018 Revocable Trust acquired 19,000 shares at a weighted average price of $59.88, bringing its reported beneficial ownership to 7,147,497 shares. The Hilltop GST Non-Exempt Descendants' Trust acquired 6,000 shares at a weighted average price of $59.86, for a reported 3,897,184 shares held after the transaction.
Additional indirect holdings include 805,920 shares held by The Sunnyridge GST Exempt Family Trust and 334 shares held by the Hamilton-Steers 2017 Trust FB Robert H. Steers, plus 139,747 shares reported as directly owned. The filing notes that Mr. Steers disclaims beneficial ownership of certain trust-held shares except to the extent of his pecuniary interest.
Cohen & Steers, Inc. insider equity update: A company officer, serving as Chief Accounting Officer and Senior Vice President, reported an automatic acquisition of 46 shares of Cohen & Steers common stock on 11/20/2025. These shares were received at a price of $0 as dividend equivalent restricted stock units tied to the issuer's fourth quarter 2025 dividend.
These dividend equivalents accrued on unvested restricted stock units originally granted in January 2022, January 2023, January 2024, and January 2025. Following this transaction, the reporting person beneficially owns 21,321 shares of Cohen & Steers common stock in direct ownership form.
Cohen & Steers, Inc. (CNS) reported an insider equity award for its President and Chief Investment Officer on a Form 4. On 11/20/2025, the executive acquired 769 shares of common stock at a price of $0, increasing his directly held position to 144,543 shares.
The filing explains that these 769 shares represent dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend. They accrued on previously granted unvested restricted stock units from awards made in January 2022, January 2023, January 2024, and January 2025, reflecting routine compensation-linked accruals rather than an open-market purchase.
Cohen & Steers, Inc. (CNS) reported a routine insider equity award for one of its officers, who serves as GC, Secretary and EVP. On 11/20/2025, the officer acquired 223 shares of common stock at a price of $0 per share.
The filing explains that these shares represent dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend, accruing on unvested restricted stock units originally granted in January 2022, January 2023, January 2024 and January 2025. Following this transaction, the officer directly holds 68,390 shares of Cohen & Steers common stock.
Cohen & Steers, Inc. insider activity: A Form 4 reports transactions by a director and 10% owner of CNS, Martin Cohen. On 11/18/2025, 100,000 shares of common stock were disposed of at a price of $0 through a transaction coded "G", reflecting a gift from the Martin Cohen 2018 Revocable Trust, which then held 8,071,461 shares indirectly.
On the same day, the reporting person bought 50,000 shares at a weighted average price of $59.69. Additional open-market purchases followed: 22,633 shares on 11/19/2025 at $59.5, 14,659 shares on 11/19/2025 at $59.91, and 12,708 shares on 11/20/2025 at $60.83. After these purchases, the reporting person directly owned 949,205 common shares.
FAQ
What is the current stock price of Cohen & Steers (CNS)?
What is the market cap of Cohen & Steers (CNS)?
